Trial Profile
A Phase 1 Study to Evaluate the Effects of Common Cold and of Concomitant Administration of Nasal Decongestant on the Pharmacokinetics and Pharmacodynamics of a Novel Glucagon Formulation in Otherwise Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 24 May 2016 New trial record